期刊文献+

鼻咽癌移植瘤动物模型的建立及其肿瘤生物学特性观察 被引量:1

The establishment of nasopharyngeal carcinoma (NPC) animal model and observation of biologic characteristics from NPC
下载PDF
导出
摘要 目的研究并优化建立鼻咽癌移植瘤动物模型的成熟方法,观察移植瘤的肿瘤生物学特性。方法采用免疫组化(SP)法,对鼻癌细胞株CNE-2对数生长期瘤细胞爬片行EB病毒潜伏膜蛋白2A(LMP-2A)免疫组化检测。对数生长期瘤细胞,分别以5×105/0.2ml,1×106/0.2ml,2×106/0.2ml,4×106/0.2ml及肿瘤组织接种于裸小鼠右侧前肢肩背部皮下,观察移植瘤生物学特性,并取肿瘤行常规病理切片及LMP2A免疫组化检测。结果BALB/c裸小鼠接种CNE-2细胞后,2×106/0.2ml组和4×106/0.2ml组移植瘤成功,3周左右接种部位皮下出现肉眼可见的瘤体肿块,逐渐增大,约4周进入加速期,其致瘤成功率为83.3%;瘤块包埋的裸鼠移植瘤成活率100%,无潜伏期,成功率显著高于另两组(P<0.01)。经病理及免疫组化证实移植瘤成功。病理提示肿瘤长至直径约1.0cm以上时,瘤体中央见坏死区域。结论皮下接种CNE-2细胞成瘤的难易与肿瘤细胞浓度成正相关,2~3×106/0.2ml的肿瘤细胞接种是较为理想的浓度。当肿瘤直径为0.5~0.8cm大小时进行干预研究是理想时机。 Objective To investigate and optimize the method of the establishment of NPC animal model, and to observe biologic characteristics from NPC. Methods The expression of EBV LMP2A in CNE-2 was detected by S-P immunohistochemical methods. BALB/C nude mouse were subcutaneously injected with 5×10^5/0.2ml, 1×10^6/0. 2ml, 2×10^6/0. 2ml, 4×10^6/0. 2ml CNE-2 cells to establish NPC animal models. The tumor characteristics and pathological features were observed. Results NPC animal models were established successfully, which was proved by pathological finding and S-P immunohistochemistry. The tumor tissues of mouse revealed positive expression of EBV-LMP2A, According to pathological finding, necrogenous reaction was observed in the middle of the tumor when the diameter of the tumor was over 1.0cm. Conclusions The concentration of CNE-2 ceils, 2-3 ×10^6/0. 2ml, is the best choice to build NPC animal models, and it suggests that we should intervene the tumor model when the diameter of the tumor is between 0.5cm and 0.8cm.
出处 《齐齐哈尔医学院学报》 2007年第18期2183-2184,2187,F0004,共4页 Journal of Qiqihar Medical University
关键词 鼻咽癌 移植瘤 动物模型 Nasopharyngeal carcinoma Transplanted tumor Animal model
  • 相关文献

参考文献4

二级参考文献20

  • 1Khanna R,Busson P,Burrows SR,et al.Molecular characterization of antigen-processing function in Nasopharyngeal Carcinoma (NPC):Evidence for efficient presentation of Epstein-Barr virus cytotoxic T-cell epitopes by NPC cells.Cancer Res,1998,58:310-314.
  • 2Konishi K,Maruo S,Kato H,et al.Role of Epstein-Barr virus-encoded latent membrane protein 2A on virus-induced immortalization and virus activation.J Gen Virol,2001,82:1451-1456.
  • 3Redchenko IV,Rickinson AB.Accessing Epstein-Barr virus specific T-cell memory with peptide-loaded dendritic cells.J Virol,1999,73:334-342.
  • 4Zhang HY,Yao K,Zhu HC,et al.Expression of the Epstein-Barr virus genome in nasopharyngeal carcinoma epithelial cell line.Int J Cancer,1990,46:944-949.
  • 5Niedobitek G.Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma.Mol Pathol,2000,53:248-254.
  • 6Murray RJ,Kurilla MG,Brooks JM,et al.Identification of target antigens for the human cytotoxic T-cell response to Epstein-Barr virus (EBV):implications for the immune control of EBV-positive malignancies.J Exp Med,1992,176:157-168.
  • 7Lee SP,Tierney RJ,Thomas WA,et al.Conserved CTL epitopes within EBV latent membrane protein 2:a potential target for CTL-based tumor therapy.J Immunol,1997,158:3325-3334.
  • 8Su Z,Peluso M,Raffegerst SH,et al.The generation of LMP2a-specific cytotoxic T lymphocytes for the treatment of patients with Epstein-Barr virus-positive Hodgin disease.Eur J Immunol,2001,31:947-958.
  • 9Gahn B,Siller-Lopez F,Pirooz AD,et al.Adenoviral gene transfer into dendritic cells efficiently amplifies the immune response to LMP2A antigen:a potential treatment strategy for Epstein-Barr virus-positive Hodgkin's lymphoma.Int J Cancer,2001,93:706-713.
  • 10Huang AY,Golumbek P,Ahmadzadeh M,et al.Role of bone marrow-derived cells in presenting MHC class I-restricted tumor antigens.Science,1994,264:961-965.

共引文献4

同被引文献17

  • 1谢良喜,李德锐,林昆,陈炯玉,洪超群.三氧化二砷对鼻咽癌BALB/c小鼠移植瘤的放射增敏作用[J].中华放射医学与防护杂志,2005,25(1):49-52. 被引量:10
  • 2焦伟,周微雅,张兴,王培中,黎而介,黄立国,陆胜经,曾毅,于庚庚,腾智平.人鼻咽癌肝转移灶裸小鼠移植瘤模型(CNT—1)的建立及特性研究[J].广西医学,1995,17(1):10-12. 被引量:1
  • 3肖志强,姚开泰,刘薇,卢光.携带EB病毒潜伏膜蛋白基因转基因小鼠的制备[J].生物化学与生物物理进展,1995,22(2):149-154. 被引量:6
  • 4陈昕,文庆莲,邓红梅,刘安敏.裸鼠不同部位皮下接种鼻咽癌瘤块成瘤特点比较[J].泸州医学院学报,2006,29(3):242-243. 被引量:3
  • 5Rogers KS,Walker MA,Helman RG.Squamous cell carcinoma of the canine nasal cavity and frontal sinus: eight cases[J].J Am Anim Hosp Assoc,1996,32(2):103-110.
  • 6Dorn CR,Priester WA.Epidemiologic analysis of oral and pharyngeal cancer in dogs,cats,horses,and cattle[J].J Am Vet Med Assoc,1976,169(11):1202-1206.
  • 7Klein G,Giovanella BC,Lindahl T,et al.Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx[J].Proc Natl Acad Sci U S A,1974,71(12):4737-4741.
  • 8Liu T,Ding Y,Xie W,et al.An imageable metastatic treatment model of nasopharyngeal carcinoma[J].Clin Cancer Res,2007,13(13):3960-3967.
  • 9Gilligan KJ,Rajadurai P,Lin JC,et al.Expression of the Epstein-Barr virus BamHI A fragment innasopharyngeal carcinoma: evidence for a viral protein expressed in vivo[J].J Virol,1991,65.
  • 10Seto E,Ooka T,Middeldorp J,et al.Reconstitution of nasopharyngeal carcinoma-type EBVinfection induces tumorigenicity[J].Cancer Res,2008,68(4):1030-1036.

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部